Skip to main content
Go to the home page of the European Commission (opens in new window)
English en
CORDIS - EU research results
CORDIS

SUPRAmolecular Hydrogel Driven Assembly of Designer Heart Tissues

Project description

Building synthetic heart tissues

Engineered heart tissues (EHTs) are essential to the study of cardiac function and new drug screening, but current models rely on natural scaffolds such as collagen, which limit reproducibility, tunability, and scalability. This prevents high-throughput screening and dulls the development of effective therapy. Building a totally synthetic, tunable matrix could overcome these impediments. In this context, the ERC-funded SUPRAHEART project will use squaramide-derived hydrogels to develop EHTs with greater scalability and mechanical tunability. The aim is to optimise hydrogel synthesis, characterise their properties, and develop protocols for generating functional cardiac tissue. In addition, SUPRAHEART will explore commercialisation, IP protection, and possible licensing, paving the way for the next generation of drug-testing platforms.

Objective

The SUPRAHEART proof-of-concept project aims to use our squaramide-based (SQ) filamentous double network hydrogels for assembly of engineered heart tissues (EHTs). As the current dependency of EHTs on natural materials (e.g. collagen I, Matrigel) limits their large-scale application as cardiac models, their generation using a fully synthetic matrix will provide improved reproducibility, tunability and scalability, opening the door for their use as a high-throughput pharmaceutical testing platform. Expanding on our development of bioactive and mechanically tunable squaramide-based hydrogels for the 3D culture of a broad range of cell types, we will scale-up the synthesis of the needed squaramide materials, perform in- depth characterization of the structural and mechanical properties of formed hydrogels, develop protocols to generate EHTs in the squaramide hydrogels and evaluate the quality of the formed tissues within the materials. In parallel with these activities, we will prepare a business plan that presents a roadmap to market, perform detailed market research on these mechanically tunable hydrogels for 3D cell culture and protect our intellectual property (IP) position. Should a patent application be successful, we will collaborate with local partners for commercialization through product licensing.

Fields of science (EuroSciVoc)

This project has not yet been classified with EuroSciVoc.
Be the first one to suggest relevant scientific fields and help us improve our classification service

Programme(s)

Topic(s)

Funding Scheme

HORIZON-ERC-POC - HORIZON ERC Proof of Concept Grants

See all projects funded under this funding scheme

Call for proposal

(opens in new window) ERC-2024-POC

See all projects funded under this call

Host institution

UNIVERSITEIT LEIDEN
Net EU contribution
€ 150 000,00
Address
RAPENBURG 70
2311 EZ Leiden
Netherlands
Activity type
Higher or Secondary Education Establishments
Links
Total cost
No data

Beneficiaries (1)